MSInsight

French tech company | Builders Republic

About

Cancer-diagnostics company whose MSIcare software detects microsatellite instability, a biomarker that predicts whether a tumor will respond to immunotherapy — combining bioinformatics and gene sequencing, validated on tumor tissue and extending to non-invasive blood-based testing.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2022
City
PARIS
Region
IDF
Tracked rounds
1
Amount raised
1.6 M€ raised since 2020

Funding rounds

  • Seed — 2025

Investors